A comparison between wet needling and prolotherapy in management of acute on chronic myofascial pain syndrome

A prospective study to compare the efficacy of prolotherapyvs needling of muscle trigger points(MTrPs) in the management of acute on chronic myofacial pain syndrome in a tertiary care in India

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036393

Enrollment

Registered

2021-09-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Prolotherapy: Injection of 1ml 25% dextrose mixed with 1ml 0.5% Bupivacaine for each myofascial trigger points Control Intervention1: Needling: 1ml 0.5% Bupivacaine is injected into eac

Eligibility

Inclusion criteria

Inclusion criteria: Myofascial pain syndrome VAS >5

Exclusion criteria

Exclusion criteria: History of trauma Fibromyalgia Neuropathy, Radiculopathy,Arthritis, Spondylosis Listhesis of vertebra, Pain as apart of generalised disease Connective tissue disorders other neurological and orthopaedic conditions that manifest as a muscle spam

Design outcomes

Primary

Measure	Time frame
Visual analog scaleTimepoint: At time of intervention and after 1 month and 3 months	—

Secondary

Measure	Time frame
Oswestry disability index Clinical global impressionTimepoint: At time of intervention and after 1 month and 3 months	—

Countries

India

Contacts

Public ContactDr Ravi Sankaran

Amrita institute of medical sciences, kochi

neeharakesya123@gmail.com8547417758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026